We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community
are mainly addressed to be used in hematologic, oncologic, urologic and neurologic pathologies as well as rare diseases
08/07/2024
Bioprofarma Bagó replaces TARGRETIN® with IMPILO®bexarotene.
03/06/2024
(Español) Nos complace presentarles nuestro nuevo producto HUTUS® enzalutamida para cáncer de próstata
16/11/2023
November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at La Rural, in the City of Buenos Aires, and Bioprofarma Bago was there.